Nexalin Technology (NXL) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precision Optics is the larger company by market cap ($50.3 million vs $3.0 million), about 16.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NXL | POCI |
|---|---|---|
| Share price | $3.63 | $4.58 |
| Market cap | $3.01M | $50.26M |
| 1-day change | -11.68% | -1.82% |
| YTD return | — | +9.31% |
| 1-year return | — | +5.53% |
| 5-year return | — | -30.61% |
| Forward P/E | — | 152.67 |
| EPS (TTM) | $-14.10 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.70 | $6.15 |
| 52-week low | $3.50 | $3.55 |
| Distance from 52-week high | -92.84% | -25.53% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +313.22% | +74.67% |
| Average volume | 1.02M | 51.88K |
| Shares outstanding | 829.40K | 10.97M |
| Employees | 8 | 108 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precision Optics is about 16.7 times larger than Nexalin Technology by market value ($50.26M vs $3.01M).
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
NXL vs POCI FAQ
Which is bigger, Nexalin Technology or Precision Optics?
Precision Optics (POCI) is larger, with a market capitalization of $50.26M compared with $3.01M for Nexalin Technology (NXL).
Are Nexalin Technology and Precision Optics in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.